SCHEMBL25462001

SCHEMBL25462001

c1ccc2c(c1)sc1cc(-c3ccc4cnccc4n3)ncc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR3 P46089 1/20 0.36
RAB9A P51151 7/20 0.35
MAPT P10636 3/20 0.35
ALDH1A1 P00352 1/20 0.35
HPGD P15428 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
NPC1 O15118 5/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
AR P10275 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
KDM4E B2RXH2 1/20 0.33
TP53 P04637 1/20 0.32
CASP1 P29466 1/20 0.32
MIF P14174 1/20 0.32
GABRA1 P14867 1/20 0.32
CLK1 P49759 1/20 0.32
DUSP4 Q13115 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25462000 0.90 MAP4K4 (0.42) GPR3RAB9AMAPTALDH1A1HPGD
SCHEMBL25461967 0.90 GABRA1 (0.38) GPR3RAB9AMAPTALDH1A1HPGD
SCHEMBL25461712 0.87 RAB9A (0.43) GPR3RAB9AMAPTALDH1A1HPGD
SCHEMBL25461886 0.86 RAB9A (0.44) RAB9AMAPTALDH1A1HPGDSMN1; SMN2
SCHEMBL25461851 0.85 RAB9A (0.43) RAB9AMAPTALDH1A1HPGDSMN1; SMN2
SCHEMBL25462014 0.83 GRM4 (0.39) GPR3RAB9AMAPTALDH1A1HPGD
SCHEMBL25462015 0.83 GRM4 (0.44) GPR3RAB9AMAPTALDH1A1HPGD
SCHEMBL25462095 0.81 MAPT (0.41) GPR3RAB9AMAPTALDH1A1HPGD
SCHEMBL25462002 0.81 TGFBR1 (0.41) GPR3RAB9AMAPTALDH1A1HPGD
SCHEMBL25461924 0.80 RAB9A (0.36) GPR3RAB9AMAPTALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230151020-A1 HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE WUHAN TIANMA MICROELECTRONICS CO., LTD. (CN) 2023-05-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230151020-A1 HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE OCIAD1, OCIAD2, EHD1 GPR3 4426/4885RAB9A 756/4885MAPT 2164/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.